Current perspectives on the mechanism of action of artemisinins
about
Coartem: the journey to the clinicExpression in Yeast Links Field Polymorphisms in PfATP6 to in Vitro Artemisinin Resistance and Identifies New Inhibitor ClassesPurified E255L Mutant SERCA1a and Purified PfATP6 Are Sensitive to SERCA-type Inhibitors but Insensitive to ArtemisininsArtemisinin-based combination therapies: a vital tool in efforts to eliminate malariaThe redox biology of schistosome parasites and applications for drug developmentPlasmodium falciparum parasites are killed by a transition state analogue of purine nucleoside phosphorylase in a primate animal modelArtemisinins: their growing importance in medicineEndoperoxide antimalarials: development, structural diversity and pharmacodynamic aspects with reference to 1,2,4-trioxane-based structural scaffoldAnti-inflammatory and immunoregulatory functions of artemisinin and its derivativesIn vivo antiplasmodial activity and toxicological assessment of hydroethanolic crude extract of Ajuga remotaHit-to-lead development of the chamigrane endoperoxide merulin A for the treatment of African sleeping sicknessNew targets for drug discovery against malariaAnti-plasmodial polyvalent interactions in Artemisia annua L. aqueous extract--possible synergistic and resistance mechanismsMerging traditional Chinese medicine with modern drug discovery technologies to find novel drugs and functional foodsPfCRT and PfMDR1 modulate interactions of artemisinin derivatives and ion channel blockersCryo transmission X-ray imaging of the malaria parasite, P. falciparum.Artemisinin directly targets malarial mitochondria through its specific mitochondrial activation.Update on the efficacy, effectiveness and safety of artemether-lumefantrine combination therapy for treatment of uncomplicated malaria.Antiprotozoal, anticancer and antimicrobial activities of dihydroartemisinin acetal dimers and monomers.Artemether-lumefantrine: an option for malaria.Effects of different concentrations of artemisinin and artemisinin-iron combination treatment on Madin Darby Canine Kidney (MDCK) cells.The dynamics of naturally acquired immunity to Plasmodium falciparum infectionArtesunate tolerance in transgenic Plasmodium falciparum parasites overexpressing a tryptophan-rich protein.Time-to-infection by Plasmodium falciparum is largely determined by random factors.Nutrient-sensitized screening for drugs that shift energy metabolism from mitochondrial respiration to glycolysis.Synthesis of artemiside and its effects in combination with conventional drugs against severe murine malariaPhenotypic and genotypic analysis of in vitro-selected artemisinin-resistant progeny of Plasmodium falciparumArtemether-Lumefantrine Combination Therapy for Treatment of Uncomplicated Malaria: The Potential for Complex Interactions with Antiretroviral Drugs in HIV-Infected Individuals.Intravenous pharmacokinetics, oral bioavailability, dose proportionality and in situ permeability of anti-malarial lumefantrine in rats.Current advances in detection and treatment of babesiosisRecent advances in the search for antiviral agents against human papillomaviruses.Repurposing the anti-malarial drug artesunate as a novel therapeutic agent for metastatic renal cell carcinoma due to its attenuation of tumor growth, metastasis, and angiogenesis.Mefloquine exposure induces cell cycle delay and reveals stage-specific expression of the pfmdr1 gene.Artemether/lumefantrine in the treatment of uncomplicated falciparum malaria.Ca(2+) monitoring in Plasmodium falciparum using the yellow cameleon-Nano biosensor.In vitro and in vivo treatments of echinococcus protoscoleces and metacestodes with artemisinin and artemisinin derivativesInhibition of Glutathione Biosynthesis Sensitizes Plasmodium berghei to Antifolates.The Curative and Prophylactic Effects of Xylopic Acid on Plasmodium berghei Infection in Mice.Ascorbic acid co-administration with artemisinin based combination therapies in falciparum malaria.Artemisinin induces doxorubicin resistance in human colon cancer cells via calcium-dependent activation of HIF-1alpha and P-glycoprotein overexpression.
P2860
Q21034131-5E2945A8-2976-4D9A-A7AB-6F54F0810C91Q22061833-58979828-728D-48ED-9D4F-063282D6051FQ22061846-FC5B2661-6E6A-47D0-AA3E-0E0848771E1EQ24614989-EE059AB8-C3F1-4926-9423-C4DE8BFE1036Q26829701-A5D6CD86-D439-4D42-BA5C-F81E55EE4F3BQ27314759-65921231-11F7-4361-89B5-5D921649855CQ27489880-1B5F56CC-510B-4489-B6BA-5F45A9C64D66Q28077102-0D1BE806-4844-4404-B520-2790C5839FF8Q28083774-984A43E3-3FA3-4BDA-B836-F463CE133EFDQ28468575-849BEC7E-58BD-44D4-AB73-A69CA926169BQ28484074-ABBD0BD2-6401-4903-9A4E-7BE6F226E416Q28489108-E7F4D78E-02AC-4B06-A1AC-B4CA21C489EEQ28535139-9F9A753A-21B3-4D6F-A5C7-216B71706F40Q28743626-46F76D7C-BF56-4326-8B6E-DD2688D1C466Q28833540-041EA1FF-D7E3-40B1-AA8B-200C71BC196BQ30497710-7E4C3816-6884-4457-9E95-2DB9806FD35DQ33539757-F25A4CDA-C1BF-40BF-BE6C-4628B916AE34Q33635019-304FBEAF-139D-479B-B556-11C92E8675DEQ33670827-23F2B09C-3CA6-4419-AC31-CA05766B6586Q34267667-BF743832-7616-4156-A1A7-F74826CE9787Q34333019-1481802E-F2D6-40B5-9B1C-C57FC8E8FCD9Q34456035-4CCBC63D-598E-4B3B-8450-F96B4DBBF28EQ35004948-9BE6C533-5038-44BB-9657-AA9835FDE96FQ35030175-696364FE-CD3F-4D31-8116-B68FED911433Q35101307-D113DAD3-F85D-4C4F-9538-10DEEE9551B5Q35666544-874860DE-6CB1-4855-85C9-C4D8C9BDC20AQ35666578-8EF2EA85-DAA6-4A1B-AEEC-F4EBD1AE7172Q35692270-66BA206A-A159-42D3-B17A-F5AC15E0E80EQ35834996-00D8DEC8-4A9F-4470-A877-A72F3D53F750Q35969816-5E64B1A8-FBEE-4073-BC77-731A9430AACDQ36284493-12FDB052-BEAA-4BD9-A927-C7D1E32FC466Q36545062-B0B012C0-4EBF-4A78-99CC-A350C492D661Q36558336-8B83B9E3-FD0C-4DB5-B379-78A2B62EC14FQ36681333-E8228FFB-6931-4A74-88E8-CD4B4400BD83Q36719348-421F806F-70E1-467C-966F-D35975D621AAQ36870795-E86DA5BC-8EBE-47FB-9C38-15CD225C6780Q36887994-58156E48-AAF7-448A-B417-5DA7043DADC2Q37067576-DB278713-869B-4F77-850A-16EF9C00C611Q37186553-81A67B4D-141B-453B-9041-6677F9429E3BQ37230670-B86F5907-38E0-43EA-B321-6E261881D681
P2860
Current perspectives on the mechanism of action of artemisinins
description
2006 nî lūn-bûn
@nan
2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Current perspectives on the mechanism of action of artemisinins
@ast
Current perspectives on the mechanism of action of artemisinins
@en
Current perspectives on the mechanism of action of artemisinins
@en-gb
Current perspectives on the mechanism of action of artemisinins
@nl
type
label
Current perspectives on the mechanism of action of artemisinins
@ast
Current perspectives on the mechanism of action of artemisinins
@en
Current perspectives on the mechanism of action of artemisinins
@en-gb
Current perspectives on the mechanism of action of artemisinins
@nl
prefLabel
Current perspectives on the mechanism of action of artemisinins
@ast
Current perspectives on the mechanism of action of artemisinins
@en
Current perspectives on the mechanism of action of artemisinins
@en-gb
Current perspectives on the mechanism of action of artemisinins
@nl
P2093
P3181
P1476
Current perspectives on the mechanism of action of artemisinins
@en
P2093
Georges E. Grau
Jacob Golenser
Judith H. Waknine
Miriam Krugliak
Nicholas H. Hunt
P304
P3181
P356
10.1016/J.IJPARA.2006.07.011
P407
P577
2006-12-01T00:00:00Z